Abstract Number: 2665 • 2019 ACR/ARP Annual Meeting
Clinical Outcomes of Patients with Giant Cell Arteritis and Polymyalgia Rheumatica Symptoms Treated with Tocilizumab in Routine Clinical Practice
Background/Purpose: Approximately 50% of patients with giant cell arteritis (GCA) also have polymyalgia rheumatica (PMR) symptoms.1 The purpose of this study was to determine whether…Abstract Number: 2752 • 2019 ACR/ARP Annual Meeting
Successfull Evaluation of a Predefined Set of Anatomic Sites in the Pelvis of Patients with Polymyalgia Rheumatica Showing Extracapsular Inflammation as Visualized by Contrast Enhanced Magnetic Resonance Imaging
Background/Purpose: The diagnosis of polymyalgia rheumatica (PMR) is based on a thorough clinical evaluation of the patient - including exclusion of other diseases, since there…Abstract Number: 747 • 2019 ACR/ARP Annual Meeting
Detrimental Factors Affecting the First-year Clinical Response in Korean Patients with Polymyalgia Rheumatica
Background/Purpose: Polymyalgia rheumatica (PMR) is a chronic inflammatory disease in which patients respond well to glucocorticoids (GCs). However, a number of patients experience a flare…Abstract Number: 759 • 2019 ACR/ARP Annual Meeting
Polymyalgia Rheumatica Patients with and Without Elevated Baseline Acute Phase Reactants: Distinct Subgroups of Polymyalgia Rheumatica?
Background/Purpose: Systemic signs of inflammation such as raised CRP or ESR are a classical feature of PMR, but some patients present with normal acute phase…Abstract Number: 762 • 2019 ACR/ARP Annual Meeting
Are There Any Identifiable Triggers in Polymyalgia Rheumatica? A Matched-Control Study
Background/Purpose: As many other rheumatologic diseases, pathogenesis of Polymyalgia Rheumatica (PMR) isnot well understood. Genetic factors seem to play a role. Some studies have suggested…Abstract Number: 765 • 2019 ACR/ARP Annual Meeting
Application of Different Sets of Classification/diagnostic Criteria for Polymyalgia Rheumatica: Single Center Study of 100 Patients
Background/Purpose: Polymyalgia rheumatica (PMR) diagnosis is based on clinical and analytical features characterized by shoulder and pelvic girdle pain associated with elevated acute phase reactants.…Abstract Number: 766 • 2019 ACR/ARP Annual Meeting
Predictors of Long-term Therapy with Glucocorticoid in Polymyalgia Rheumatica
Background/Purpose: Clinical symptoms of polymyalgia rheumatica (PMR) are improved by low-dose glucocorticoids (GC), but relapses and long-term GC therapy are common. 2015 EULAR/ACR recommendations suggest…Abstract Number: 1161 • 2019 ACR/ARP Annual Meeting
Gadolinium-Enhanced Magnetic Resonance Imaging in Shoulders Contributes Accurate Diagnosis and Predicting Recurrence to Patients with Polymyalgia Rheumatica
Background/Purpose: Polymyalgia rheumatica (PMR) is a glucocorticoid-responsive muscle pain and stiffness, especially in the shoulders and hips. PMR is clinically diagnosed based on the symptoms,…Abstract Number: 1836 • 2019 ACR/ARP Annual Meeting
Clinical Outcomes of Patients with Giant Cell Arteritis with Polymyalgia Symptoms Only vs Cranial Symptoms Only Treated with Tocilizumab or Placebo in a Randomized Clinical Trial
Background/Purpose: GiACTA, a randomized, double-blind, placebo (PBO)–controlled study, demonstrated the efficacy and safety of tocilizumab (TCZ) in patients with giant cell arteritis (GCA).1 Growing evidence…Abstract Number: 2134 • 2019 ACR/ARP Annual Meeting
Extracellular Adenosine Increases IL-6 Production by Aging Tenocytes and May Contribute to the Age-related Pattern of Polymyalgia Rheumatica
Background/Purpose: Polymyalgia rheumatica (PMR) is a common disease preferentially affecting elderly patients. Characteristically, PMR involves large tendons and muscles around the hips and shoulders. While…Abstract Number: 2148 • 2019 ACR/ARP Annual Meeting
Muscle Involvement Revealed by 18F-PET-CT in Polymyalgia Rheumatica
Background/Purpose: Imaging techniques in polymyalgia rheumatica (PMR) have revealed mainly bursitis, tenosynovitis, capsulitis and enthesitis. This is also the case for 18F-FDG-PET-CT. This technique, which…Abstract Number: 2658 • 2019 ACR/ARP Annual Meeting
Giant Cell Arteritis Diagnostic Workup Among Medicare Beneficiaries
Background/Purpose: Giant cell arteritis (GCA) has traditionally been diagnosed by a combination of symptoms, clinical findings, laboratory results, and temporal artery biopsy. More recently, imaging…Abstract Number: 297 • 2018 ACR/ARHP Annual Meeting
Hospitalization Rates Among Patients with Polymyalgia Rheumatica: A Population-Based Study from 1995-2017
Background/Purpose: The study purpose was to determine whether patients with polymyalgia rheumatica (PMR) are at greater risk for all-cause hospitalizations compared to the general population.Methods:…Abstract Number: 816 • 2018 ACR/ARHP Annual Meeting
Development of Thoracic Aortic Aneurysms in Patients with Polymyalgia Rheumatica: Underdiagnosed Giant Cell Arteritis?
Background/Purpose: Polymyalgia Rheumatica (PMR) and Giant Cell Arteritis (GCA) are close-related entities. Imaging studies have suggested that subclinical inflammation of the large arteries is frequent…Abstract Number: 2286 • 2018 ACR/ARHP Annual Meeting
Myositis and Fasciitis By Magnetic Resonance Imaging in Recent-Onset Polymyalgia Rheumatica and Effect of Tocilizumab Therapy
Background/Purpose: To assess the prevalence of myofascial inflammatory lesions visible by magnetic resonance imaging (MRI) and their changes after tocilizumab therapy in active polymyalgia rheumatica…
ACR Meeting Abstracts